Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China
· Delayed Price · Currency is CNY 77.87
-0.47 (-0.60%)
May 14, 2025, 2:45 PM CST
SHA:688050 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 376.74 | 387.08 | 303.98 | 232.69 | 171.34 | 96.56 | Upgrade
|
| Depreciation & Amortization | 133.21 | 133.21 | 75.49 | 43.35 | 32.04 | 26.67 | Upgrade
|
| Other Amortization | 12.38 | 12.38 | 10.96 | 9.08 | 7.33 | 3.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -0.11 | -0.01 | -0.02 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.58 | 5.58 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.83 | 0.83 | -11.7 | -18.58 | -19.59 | -5.11 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 9.11 | 8.37 | 5.74 | 2.03 | Upgrade
|
| Other Operating Activities | 63.19 | 31.29 | -9.62 | -3.07 | -1.91 | -0.39 | Upgrade
|
| Change in Accounts Receivable | -127.09 | -127.09 | -103.52 | -45.76 | 1.12 | 18.11 | Upgrade
|
| Change in Inventory | -86.09 | -86.09 | -85.12 | -22.82 | 3.35 | 1.67 | Upgrade
|
| Change in Accounts Payable | 7.15 | 7.15 | 21.46 | 21.41 | 15.07 | -20.09 | Upgrade
|
| Change in Other Net Operating Assets | 6.11 | 6.11 | 12.39 | 17.56 | 13.25 | - | Upgrade
|
| Operating Cash Flow | 369.3 | 347.75 | 212.62 | 250.13 | 219.3 | 123.35 | Upgrade
|
| Operating Cash Flow Growth | 54.25% | 63.56% | -15.00% | 14.06% | 77.78% | 144.30% | Upgrade
|
| Capital Expenditures | -259.83 | -329.48 | -370.34 | -271.03 | -311.22 | -118.73 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.43 | 0.04 | - | 0.03 | Upgrade
|
| Cash Acquisitions | -72.53 | -72.3 | -47.03 | - | - | - | Upgrade
|
| Investment in Securities | -207.54 | -213.06 | 439.64 | -51.29 | -120.9 | -474.98 | Upgrade
|
| Other Investing Activities | 7.81 | 1.06 | 15.97 | 21.44 | 19.75 | 5.97 | Upgrade
|
| Investing Cash Flow | -532.08 | -613.76 | 32.67 | -307.84 | -420.37 | -587.71 | Upgrade
|
| Long-Term Debt Issued | - | 481.62 | 12.16 | 10 | 143.37 | - | Upgrade
|
| Long-Term Debt Repaid | - | -293.64 | -19.43 | -5.4 | - | -0.44 | Upgrade
|
| Net Debt Issued (Repaid) | 213.78 | 187.98 | -7.27 | 4.6 | 143.37 | -0.44 | Upgrade
|
| Issuance of Common Stock | 3.63 | 3.97 | 13.48 | 1.56 | 24.91 | 823.29 | Upgrade
|
| Common Dividends Paid | -72.14 | -70.56 | -61.37 | -44.44 | -30.52 | - | Upgrade
|
| Other Financing Activities | -3.22 | -23.27 | -8.41 | -26.79 | -0.02 | -18.12 | Upgrade
|
| Financing Cash Flow | 142.05 | 98.12 | -63.57 | -65.07 | 137.74 | 804.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | -0.02 | 0.04 | -0.04 | -0.64 | 0.15 | Upgrade
|
| Net Cash Flow | -20.7 | -167.91 | 181.76 | -122.82 | -63.97 | 340.51 | Upgrade
|
| Free Cash Flow | 109.47 | 18.27 | -157.72 | -20.9 | -91.92 | 4.62 | Upgrade
|
| Free Cash Flow Margin | 7.51% | 1.30% | -16.58% | -3.61% | -21.22% | 1.69% | Upgrade
|
| Free Cash Flow Per Share | 0.58 | 0.10 | -0.83 | -0.11 | -0.49 | 0.03 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.01 | Upgrade
|
| Cash Income Tax Paid | 175.18 | 157.99 | 157.93 | 58.75 | 57.3 | 36.58 | Upgrade
|
| Levered Free Cash Flow | -84 | -156.56 | -215.88 | -110.16 | -105.6 | 5.29 | Upgrade
|
| Unlevered Free Cash Flow | -84 | -156.56 | -209.74 | -108.89 | -105.14 | 5.29 | Upgrade
|
| Change in Net Working Capital | 254.62 | 264.83 | 129.54 | 50.78 | -56.01 | -33.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.